Real4Reg Summary Statistics

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Aarhus University, Danish Medicines Agency, Fraunhofer Institute for Algorithms and Scientific Computing, Infarmed, University of Eastern Finland
DOI: 10.5281/zenodo.18196002
Cited by: 0

Abstract

The document summarises key characteristics of the conditions and medications studied in Real4Reg: breast cancer, amyotrophic lateral sclerosis (ALS), antibiotic consumption and diabetes medicines. Results are presented for the participating countries where available.

Fields of Study & Subjects

Global Cancer Incidence and Screening Pharmaceutical Practices and Patient Outcomes Pharmaceutical Economics and Policy

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
9 January 2026
Language
EN